These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33818237)

  • 1. pH and ROS sequentially responsive podophyllotoxin prodrug micelles with surface charge-switchable and self-amplification drug release for combating multidrug resistance cancer.
    Li C; Wang Y; Zhang S; Zhang J; Wang F; Sun Y; Huang L; Bian W
    Drug Deliv; 2021 Dec; 28(1):680-691. PubMed ID: 33818237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ROS-Activated homodimeric podophyllotoxin nanomedicine with self-accelerating drug release for efficient cancer eradication.
    Liang B; Zhou D
    Drug Deliv; 2021 Dec; 28(1):2361-2372. PubMed ID: 34747277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transferrin receptor-targeted redox/pH-sensitive podophyllotoxin prodrug micelles for multidrug-resistant breast cancer therapy.
    Li Y; Chen M; Yao B; Lu X; Zhang X; He P; Vasilatos SN; Ren X; Bian W; Yao C
    J Mater Chem B; 2019 Oct; 7(38):5814-5824. PubMed ID: 31495855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pH-Responsive Charge-Reversal Drug Delivery System with Tumor-Specific Drug Release and ROS Generation for Cancer Therapy.
    Xu C; Song R; Lu P; Chen J; Zhou Y; Shen G; Jiang M; Zhang W
    Int J Nanomedicine; 2020; 15():65-80. PubMed ID: 32021165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pH/ROS cascade-responsive and self-accelerating drug release nanosystem for the targeted treatment of multi-drug-resistant colon cancer.
    Chang N; Zhao Y; Ge N; Qian L
    Drug Deliv; 2020 Dec; 27(1):1073-1086. PubMed ID: 32706272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH/reduction dual-responsive hyaluronic acid-podophyllotoxin prodrug micelles for tumor targeted delivery.
    Li M; Zhao Y; Sun J; Chen H; Liu Z; Lin K; Ma P; Zhang W; Zhen Y; Zhang S; Zhang S
    Carbohydr Polym; 2022 Jul; 288():119402. PubMed ID: 35450654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective self-induced stimulus amplification prodrug platform for inhibiting multidrug resistance and lung metastasis.
    Xu C; Sun Y; Qi Y; Yu Y; He Y; Hu M; Hu Q; Wu T; Zhang D; Shang L; Deng H; Zhang Z
    J Control Release; 2018 Aug; 284():224-239. PubMed ID: 29958912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Sequentially Responsive Nanosystem Breaches Cascaded Bio-barriers and Suppresses P-Glycoprotein Function for Reversing Cancer Drug Resistance.
    Liu J; Zhao L; Shi L; Yuan Y; Fu D; Ye Z; Li Q; Deng Y; Liu X; Lv Q; Cheng Y; Xu Y; Jiang X; Wang G; Wang L; Wang Z
    ACS Appl Mater Interfaces; 2020 Dec; 12(49):54343-54355. PubMed ID: 32959645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A ROS-responsive polymeric prodrug nanosystem with self-amplified drug release for PSMA (-) prostate cancer specific therapy.
    Wang Y; Zhang Y; Ru Z; Song W; Chen L; Ma H; Sun L
    J Nanobiotechnology; 2019 Aug; 17(1):91. PubMed ID: 31451114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tumor-specific ROS self-supply enhanced cascade-responsive prodrug activation nanosystem for amplified chemotherapy against multidrug-resistant tumors.
    Wang J; Zhang H; Lv J; Zheng Y; Li M; Yang G; Wei X; Li N; Huang H; Li T; Qin X; Li S; Wu C; Zhang W; Liu Y; Yang H
    Acta Biomater; 2023 Jul; 164():522-537. PubMed ID: 37072069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
    Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
    Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active-targeting and acid-sensitive pluronic prodrug micelles for efficiently overcoming MDR in breast cancer.
    Xu C; Xu J; Zheng Y; Fang Q; Lv X; Wang X; Tang R
    J Mater Chem B; 2020 Apr; 8(13):2726-2737. PubMed ID: 32154530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pH/ROS Cascade-Responsive Charge-Reversal Nanosystem with Self-Amplified Drug Release for Synergistic Oxidation-Chemotherapy.
    Dai L; Li X; Duan X; Li M; Niu P; Xu H; Cai K; Yang H
    Adv Sci (Weinh); 2019 Feb; 6(4):1801807. PubMed ID: 30828537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-sensitive hyaluronic acid-targeted prodrug micelles constructed via a one-step reaction for enhanced chemotherapy.
    Li M; Zhang L; Xuan Y; Zhi D; Wang W; Zhang W; Zhao Y; Zhang S; Zhang S
    Int J Biol Macromol; 2022 May; 206():489-500. PubMed ID: 35240214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-responsive doxorubicin-loaded nanomicelles for enhanced cancer therapy.
    Zhang X; Zhu T; Miao Y; Zhou L; Zhang W
    J Nanobiotechnology; 2020 Sep; 18(1):136. PubMed ID: 32972412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH/ROS dual-responsive supramolecular polypeptide prodrug nanomedicine based on host-guest recognition for cancer therapy.
    Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Chen T; Dong CM; Yao Y
    Acta Biomater; 2022 Apr; 143():381-391. PubMed ID: 35272024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH/redox sequentially responsive nanoparticles with size shrinkage properties achieve deep tumor penetration and reversal of multidrug resistance.
    Feng W; Zong M; Wan L; Yu X; Yu W
    Biomater Sci; 2020 Sep; 8(17):4767-4778. PubMed ID: 32724941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smart Responsive Quercetin-Conjugated Glycol Chitosan Prodrug Micelles for Treatment of Inflammatory Bowel Diseases.
    Shen C; Zhao L; Du X; Tian J; Yuan Y; Jia M; He Y; Zeng R; Qiao R; Li C
    Mol Pharm; 2021 Mar; 18(3):1419-1430. PubMed ID: 33522827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles.
    Wang Z; Li X; Wang D; Zou Y; Qu X; He C; Deng Y; Jin Y; Zhou Y; Zhou Y; Liu Y
    Acta Biomater; 2017 Oct; 62():144-156. PubMed ID: 28842335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
    Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
    Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.